HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Arden Books Gains, But Projections Were “Too Optimistic”

This article was originally published in The Rose Sheet

Executive Summary

Elizabeth Arden Inc reports a second-quarter sales increase of nearly 9%, but the firm missed its projections for the holidays. Recent launches from Justin Beiber, Nicki Minaj and Taylor Swift franchises drove sales in the US prestige category.

You may also be interested in...



Rumors Swirl Over Arden Sale, Driving Stock Price Up 27%

Reports that Elizabeth Arden is interested in selling its business – with at least one buyer supposedly interested – has sent the Miramar Fla.-based firm’s stock soaring almost 27% in two days. South Korean firm LG Household & Healthcare is purportedly mulling the purchase, which would give the Seoul-based firm a strong foothold in the North American market.

New Launches Propel Arden In Q1; Restaged Elizabeth Arden Rolling Out

Elizabeth Arden Inc. attributes increased sales in the first quarter to strong fragrance launches. Meanwhile, earnings were impacted as the firm incurred expenses related to the restaging of its flagship Elizabeth Arden brand.

Women’s Voices For The Earth Will Keep After CIR, Salon Worker Safety In 2024

Women’s Voices for the Earth continues to call attention to cosmetic ingredients’ potential health impacts on users including salon workers, while pushing the Cosmetic Ingredient Review to consider a wider variety of safety information in its assessment work.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018855

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel